Recombinant Protein For Treating Sars Cov2 Disease

Abstract: The present invention relates to the protein for treatment of infectious disease caused by Coronaviridae. In particular, the invention relates to a recombinant Sclerotium rolfsii lectin for use in the treatment, reduction in progression and curing of SARS-COV2disease in a subject in need thereof. Pharmaceutical compositions comprising said recombinant Sclerotium rolfsii lectin are also described. The recombinant Sclerotium rolfsii lectin protein may comprise an amino acid sequence having at least 70% homology to SEQ ID NO:1.

Patent Information

Application #

Filing Date

12 June 2024

Publication Number

51/2024

Publication Type

INA

Invention Field

BIOTECHNOLOGY

Status

Email

Parent Application

Applicants

UNICHEM LABORATORIES LIMITED

Unichem Bhavan, Prabhat Estate, Off. S. V. Road, Jogeshwari (W) Mumbai Maharashtra 400102

Inventors

1. SATHE, Dhananjay

202/A-1, Golden Park, L.B.S. Marg, Panchpakhadi, Thane Maharashtra 400601

2. IYAPPAN, Saravanakumar

1-6-39/108/1, Dinakar Nagar, West Venkatapuram, Alwal, Hyderabad Telangana 500015

Specification

Documents

Application Documents

#	Name	Date
1	202417045369-STATEMENT OF UNDERTAKING (FORM 3) [12-06-2024(online)].pdf	2024-06-12
3	202417045369-REQUEST FOR EXAMINATION (FORM-18) [12-06-2024(online)].pdf	2024-06-12
4	202417045369-POWER OF AUTHORITY [12-06-2024(online)].pdf	2024-06-12
5	202417045369-FORM 18 [12-06-2024(online)].pdf	2024-06-12
6	202417045369-FORM 1 [12-06-2024(online)].pdf	2024-06-12
7	202417045369-DECLARATION OF INVENTORSHIP (FORM 5) [12-06-2024(online)].pdf	2024-06-12
8	202417045369-COMPLETE SPECIFICATION [12-06-2024(online)].pdf	2024-06-12
9	202417045369-FORM 3 [14-11-2024(online)].pdf	2024-11-14